General Information of the Compound
Compound ID |
CP0396371
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-[3-[(3S,6S,9S,12R,15S)-9-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-7-methyl-3-(naphthalen-2-ylmethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]propyl]guanidine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C37H46N8O7
|
||||||||||||||||||
Molecular Weight |
714.824
|
||||||||||||||||||
Canonical SMILES |
CN1[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C37H46N8O7/c1-44-30(8-4-16-40-37(38)39)33(49)42-28(20-23-10-13-24-6-2-3-7-25(24)18-23)36(52)45-17-5-9-31(45)34(50)41-27(19-22-11-14-26(47)15-12-22)32(48)43-29(21-46)35(44)51/h2-3,6-7,10-15,18,27-31,46-47H,4-5,8-9,16-17,19-21H2,1H3,(H,41,50)(H,42,49)(H,43,48)(H4,38,39,40)/t27-,28+,29+,30+,31+/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
UJQXTFFFQMOHCE-LVIOGHJBSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04108, Atypical chemokine receptor 3
Protein ID: PT02059, C-X-C chemokine receptor type 4